Molecules and Cells

Korean Society for Molecular and Cellular Biology (한국분자세포생물학회)
권호 표지
DOI QR코드

DOI QR Code

Transmembrane Helix of Novel Oncogene with Kinase-Domain (NOK) Influences Its Oligomerization and Limits the Activation of RAS/MAPK Signaling

  • Li, Ying-Hua (Institute of Biomedicine and School of Medicine, Tsinghua University) ;
  • Wang, Yin-Yin (Institute of Biomedicine and School of Medicine, Tsinghua University) ;
  • Zhong, Shan (Institute of Biomedicine and School of Medicine, Tsinghua University) ;
  • Rong, Zhi-Li (Institute of Biomedicine and School of Medicine, Tsinghua University) ;
  • Ren, Yong-Ming (Institute of Biomedicine and School of Medicine, Tsinghua University) ;
  • Li, Zhi-Yong (Institute of Biomedicine and School of Medicine, Tsinghua University) ;
  • Zhang, Shu-Ping (Institute of Biomedicine and School of Medicine, Tsinghua University) ;
  • Chang, Zhi-Jie (Institute of Biomedicine and School of Medicine, Tsinghua University) ;
  • Liu, Li (Institute of Biomedicine and School of Medicine, Tsinghua University)
  • Received : 2008.06.17
  • Accepted : 2008.10.28
  • Published : 2009.01.31
⟨ Previous Next ⟩

Abstract

Ligand-dependent or independent oligomerization of receptor protein tyrosine kinase (RPTK) is often an essential step for receptor activation and intracellular signaling. The novel oncogene with kinase-domain (NOK) is a unique RPTK that almost completely lacks an ectodomain, expresses intracellularly and activates constitutively. However, it is unknown whether NOK can form oligomer or what function oligomerization would have. In this study, two NOK deletion mutants were generated by either removing the ectodomain ($NOK{\Delta}ECD$) or including the endodomain (NOK-ICD). Co-immunoprecipitation demonstrated that the transmembrane (TM) domain of NOK was essential for its intermolecular interaction. The results further showed that NOK aggregated more closely as lower order oligomers (the dimer- and trimer-sized) than either deletion mutant did since NOK could be crosslinked by both Sulfo-EGS and formaldehyde, whereas either deletion mutant was only sensitive to Sulfo-EGS. Removing the NOK TM domain (NOK-ICD) not only markedly promoted higher order oligomerization, but also altered the subcellular localization of NOK and dramatically elevated the NOK-mediated constitutive activation of extracellular signal-regulated kinase (ERK). Moreover, NOK-ICD but not NOK or $NOK{\Delta}ECD$ was co-localized with the upstream signaling molecule RAS on cell membrane. Thus, TM-mediated intermolecular contacting may be mainly responsible for the constitutive activation of NOK and contribute to the autoinhibitory effect on RAS/MAPK signaling.

Keywords

Acknowledgement

Supported by : National Natural Science Foundation of China

References

  1. Amachika, T., Kobayashi, D., Moriai, R., Tsuji, N., and Watanabe, N. (2007). Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancers. Lung Cancer 56, 337-340 https://doi.org/10.1016/j.lungcan.2007.01.002
  2. Bartkiewicz, M., Houghton, A., and Baron, R. (1999). Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor. J. Biol. Chem. 274, 30887-30895 https://doi.org/10.1074/jbc.274.43.30887
  3. Blume-Jensen, P., and Hunter, T. (2001). Oncogenic kinase signalling. Nature 411, 355-365 https://doi.org/10.1038/35077225
  4. Brennan, P.J., Kumagai, T., Berezov, A., Murali, R., and Greene, M.I. (2000). HER2/neu: mechanisms of dimerization/oligomerization. Oncogene 19, 6093-6101 https://doi.org/10.1038/sj.onc.1203967
  5. Chen, Y., Li, Y.H., Chen, X.P., Gong, L.M., Zhang, S.P., Chang, Z.J., Zhang, X.F., Fu, X.Y., and Liu, L. (2005). Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice. Cancer Res 65, 10838-10846 https://doi.org/10.1158/0008-5472.CAN-05-1091
  6. Clayton, A.H., Walker, F., Orchard, S.G., Henderson, C., Fuchs, D., Rothacker, J., Nice, E.C., and Burgess, A.W. (2005). Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis. J. Biol. Chem. 280, 30392-30399 https://doi.org/10.1074/jbc.M504770200
  7. Fan, P.D., Cong, F., and Goff, S.P. (2003). Homo- and heterooligomerization of the c-Abl kinase and Abelson-interactor-1. Cancer Res. 63, 873-877
  8. Guy, P.M., Platko, J.V., Cantley, L.C., Cerione, R.A., and Carraway, K.L., 3rd. (1994). Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl. Acad. Sci. USA 91, 8132-8136 https://doi.org/10.1073/pnas.91.17.8132
  9. Hubbard, S.R. (2002). Autoinhibitory mechanisms in receptor tyrosine kinases. Front Biosci. 7, d330-340 https://doi.org/10.2741/hubbard
  10. Jiang, G., and Hunter, T. (1999). Receptor signaling: When dimerization is not enough. Curr. Biol. 9, R568-R571 https://doi.org/10.1016/S0960-9822(99)80357-1
  11. Kani, K., Warren, C.M., Kaddis, C.S., Loo, J.A., and Landgraf, R. (2005). Oligomers of $ERBB_{3}$ have two distinct interfaces that differ in their sensitivity to disruption by heregulin. J. Biol. Chem. 280, 8238-8247 https://doi.org/10.1074/jbc.M410944200
  12. Kimbro, K.S., Duschene, K., Willard, M., Moore, J.A., and Freeman, S. (2008). A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptorbeta positive breast cancer cells following estrogen treatment. Mol. Biol. Rep. 35, 23-27 https://doi.org/10.1007/s11033-006-9047-1
  13. Li, E., and Hristova, K. (2006). Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry 45, 6241-6251 https://doi.org/10.1021/bi060609y
  14. Li, Y.H., Zhong, S., Rong, Z.L., Ren, Y.M., Li, Z.Y., Zhang, S.P., Chang, Z., and Liu, L. (2007). The carboxyl terminal tyrosine 417 residue of NOK has an autoinhibitory effect on NOKmediated signaling transductions. Biochem. Biophys. Res. Commun. 356, 444-449 https://doi.org/10.1016/j.bbrc.2007.02.154
  15. Li, Y.H., Chang, Z.J., and Liu, L. (2008a). NOK interacts with Akt and enhances its activation. Prog. Biochem. Biophys. 35, 29-34
  16. Li, Y.H., Rong, Y., Chang, Z J., and Liu, L. (2008b). NOK activates STAT3 signaling by a JAK2-dependent mechanism. Prog. Biochem. Biophys. 35, 143-150
  17. Liu, L., Yu, X.Z., Li, T.S., Song, L.X., Chen, P.L., Suo, T.L., Li, Y.H., Wang, S.D., Chen, Y., Ren, Y.M., et al. (2004). A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice. Cancer Res. 64, 3491-3499 https://doi.org/10.1158/0008-5472.CAN-03-2106
  18. Manning, G., Whyte, D.B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002). The protein kinase complement of the human genome. Science 298, 1912-1934 https://doi.org/10.1126/science.1075762
  19. McWhirter, J.R., Galasso, D.L., and Wang, J.Y. (1993). A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13, 7587-7595 https://doi.org/10.1128/MCB.13.12.7587
  20. Mohammadi, M., Honegger, A., Sorokin, A., Ullrich, A., Schlessinger, J., and Hurwitz, D.R. (1993). Aggregationinduced activation of the epidermal growth factor receptor protein tyrosine kinase. Biochemistry 32, 8742-8748 https://doi.org/10.1021/bi00085a004
  21. Moriai, R., Kobayashi, D., Amachika, T., Tsuji, N., and Watanabe, N. (2006). Diagnostic relevance of overexpressed NOK mRNA in breast cancer. Anticancer Res. 26, 4969-4973
  22. Ozaki, K., Miyazaki, S., Tanimura, S., and Kohno, M. (2005). Efficient suppression of FGF-2-induced ERK activation by the cooperative interaction among mammalian Sprouty isoforms. J. Cell Sci. 118, 5861-5871 https://doi.org/10.1242/jcs.02711
  23. Pluk, H., Dorey, K., and Superti-Furga, G. (2002). Autoinhibition of c-Abl. Cell 108, 247-259 https://doi.org/10.1016/S0092-8674(02)00623-2
  24. Robinson, D.R., Wu, Y.M., and Lin, S.F. (2000). The protein tyrosine kinase family of the human genome. Oncogene 19, 5548-5557 https://doi.org/10.1038/sj.onc.1203957
  25. Schlessinger, J. (2002). Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110, 669-672 https://doi.org/10.1016/S0092-8674(02)00966-2
  26. Simpson, J.C., Wellenreuther, R., Poustka, A., Pepperkok, R., and Wiemann, S. (2000). Systematic subcellular localization of novel proteins identified by large scale cDNA sequencing. EMBO Rep. 1, 287-292 https://doi.org/10.1093/embo-reports/kvd058
  27. Smith, K.M., Yacobi, R., and Van Etten, R.A. (2003). Autoinhibition of Bcr-Abl through its SH3 domain. Mol. Cell 12, 27-37 https://doi.org/10.1016/S1097-2765(03)00274-0
  28. Tong, Q., Xing, S., and Jhiang, S.M. (1997). Leucine zippermediated dimerization is essential for the $PTC_{1}$ oncogenic activity. J. Biol. Chem. 272, 9043-9047 https://doi.org/10.1074/jbc.272.14.9043
  29. Ye, X., Ji, C., Huang, Q., Cheng, C., Tang, R., Xu, J., Zeng, L., Dai, J., Wu, Q., Gu, S., et al. (2003). Isolation and characterization of a human putative receptor protein kinase cDNA STYK1. Mol. Biol. Rep. 30, 91-96 https://doi.org/10.1023/A:1023934017174
  30. Yu, X., Sharma, K.D., Takahashi, T., Iwamoto, R., and Mekada, E. (2002). Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol. Biol. Cell 13, 2547-2557 https://doi.org/10.1091/mbc.01-08-0411

Cited by

  1. LRRK2 in Parkinson’s disease: function in cells and neurodegeneration vol.276, pp.22, 2009, https://doi.org/10.1111/j.1742-4658.2009.07342.x
  2. Dissection of the dimerization modes in the DJ-1 superfamily vol.33, pp.2, 2012, https://doi.org/10.1007/s10059-012-2220-6
  3. Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer vol.14, pp.None, 2009, https://doi.org/10.1186/1471-2407-14-402
  4. Diagnostic Relevance of Overexpressed Serine Threonine Tyrosine Kinase/Novel Oncogene with Kinase Domain (STYK1/NOK) mRNA in Colorectal Cancer vol.15, pp.16, 2009, https://doi.org/10.7314/apjcp.2014.15.16.6685
  5. Depletion of STYK1 inhibits intrahepatic cholangiocarcinoma development both in vitro and in vivo vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5188-6
  6. STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I vol.16, pp.10, 2009, https://doi.org/10.1080/15548627.2019.1687212